A team of researchers from the Florida State University College of Medicine has found that an amino acid produced by the brain could play a crucial role in preventing a type of epileptic seizure.
Seizure forecasting may provide patients with timely warnings to adapt their daily activities and help clinicians deliver more objective, personalized treatments.
Genetics, Pediatric Epilepsy, SUDEP
A round-up of epilepsy news from the past month.
Existing classifications schemes should be better suited to field conditions in resource-limited communities in low- and middle-income countries. The finding of drug resistant epilepsy in nearly at least a third in a community-based sample underscores an unmet need for enhancing services for this segment within healthcare systems.
Researchers quantified the risk of stroke following epileptic seizures in this case-control analysis based on Swedish national registers. The risk appeared to be especially high in the first year after seizure diagnosis; this finding lends support to the notion that unexplained late-onset seizures may merit prompt evaluation of vascular risk profile.
The pandemic is a new setback for women in academia who already faced obstacles on the path to advancing their research and careers.
Pediatric Epilepsy
In recently published randomized controlled trials, fenfluramine (FFA) proved to be safe and effective in Dravet Syndrome.
The aim of this study is to describe children with epilepsy onset before 2 years of age, and to explore to what degree whole exome and whole genome sequencing (WES/WGS) can help reveal a molecular genetic diagnosis.
NAYZILAM® (midazolam) nasal spray, a rescue medicine manufactured by UCB, is experiencing a manufacturing delay. This shortage is expected to be temporary, lasting until the end of October 2020.
